Case Study
2026 Segment-Specific Industry Update Brand/Innovator Drugs, Generics, Biotech, Cell & Gene Therapy and PBM’s
The global branded drug segment continues to represent the largest share of pharmaceutical value,driven by high-value specialty medicines and sustained investment in innovation. In 2025, growthremains concentrated in therapeutic areas where clinical differentiation, durable intellectual property, and integrated patient support models can justify premium pricing.
Please fill out the form to download the Case Study or Slide Deck
Thank you. We'll be in touch shortly.
Oops! Something went wrong while submitting the form.